Third Vaccine Dose Cuts COVID-19-Related Mortality in Adults With Chronic Conditions
For adults with 2 or more chronic conditions, a third dose of BNT162b2 or CoronaVac was linked to a reduction in mortality.
Diagnosis & Disease Information
FDA Panel Says Bivalent Shots, Not Original COVID-19 Vaccines, Should Be Standard
The FDA’s vaccine advisory panel has recommended that the FDA phase out the original versions of the COVID-19 vaccines in favor of the updated bivalent booster shots.
Bivalent COVID-19 Vaccines May Provide Protection Against BA.5, XBB/XBB.1.5
The bivalent COVID-19 vaccines seem to provide protection against symptomatic infection with BA.5 and XBB/XBB.1.5 SARS-CoV-2 variants.
Uptake Low for COVID-19 Vaccine Boosters in Immunocompromised Adults
Most immunocompromised adults studied did not adhere to CDC recommendations regarding booster doses of the monovalent COVID-19 vaccines.
FDA Proposes Making COVID-19 Vaccinations an Annual Occurrence
The FDA has asked its vaccine advisory committee to consider a proposal to turn COVID-19 vaccines into an annual shot for most Americans.
Cancer Patients Have Higher Risk of Breakthrough COVID-19, Poor Outcomes
Patients with cancer have a higher risk of breakthrough SARS-CoV-2 infection and worse COVID-19 outcomes than patients without cancer.
COVID-19 Vaccine Inhaled Through the Mouth Launched in China
The inhaled vaccine was approved in September by Chinese regulators after completing trials in China, Hungary, Pakistan, Malaysia, Argentina, and Mexico.
Pfizer Plans to Charge More Than $100 Per COVID-19 Shot in 2023
People with Medicare or Medicaid and those with private health insurance would likely get the vaccine for free, according to a Pfizer executive.
COVID-19 Vaccination Should Not Interrupt ICI Therapy, Researchers Say
COVID-19 vaccination is safe for cancer patients receiving immune checkpoint inhibitors and should not interrupt therapy, according to researchers.
FDA Authorizes Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted
The booster dose elicited robust antibody responses comparable to or exceeding levels associated with the efficacy data in the primary series of the vaccine.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...